Result And NotAnita Rachlis

List of bibliographic references

Number of relevant bibliographic references: 12.

Ident.	Authors (with country if any)	Title
000C92	Dave Mclean [Nouvelle-Zélande] ; Sarah Fleming [Royaume-Uni] ; Michelle C. Turner [Espagne] ; Laurel Kincl [États-Unis] ; Lesley Richardson [Canada] ; Geza Benke [Australie] ; Brigitte Schlehofer [Allemagne] ; Klaus Schlaefer [Allemagne] ; Marie-Elise Parent [Canada] ; Martine Hours [France] ; Daniel Krewski [Canada] ; Martie Van Tongeren [Royaume-Uni] ; Siegal Sadetzki [Israël] ; Jack Siemiatycki [Canada] ; Elisabeth Cardis [Espagne]	Occupational solvent exposure and risk of meningioma: results from the INTEROCC multicentre case-control study
000E87	J. F. Lester [Royaume-Uni] ; J. Agulnik [Canada] ; O. Akerborg [Suède] ; C. Chouaid [France] ; A. De Geer [Suède] ; H. W. Finnern [États-Unis] ; G. J. M. Herder [Pays-Bas] ; J. Lungershausen [Allemagne] ; P. L. R. Mitchell [Australie] ; J. Vansteenkiste [Belgique] ; C. Ziske [Allemagne] ; E. Goker [Turquie]	What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?-Results from the lung cancer economics and outcomes research (LUCEOR) study
000F42	Stefan Zeuzem [Allemagne] ; Tarik Asselah [France] ; Peter Angus [Australie] ; Jean-Pierre Zarski [France] ; Dominique Larrey [France] ; Beat Müllhaupt [Suisse] ; Ed Gane [Nouvelle-Zélande] ; Marcus Schuchmann [Allemagne] ; Ansgar W. Lohse [Allemagne] ; Stanislas Pol [France] ; Jean-Pierre Bronowicki [France] ; Stuart Roberts [Australie] ; Keikawus Arasteh [Allemagne] ; Fabien Zoulim [France] ; Markus Heim [Suisse] ; Jerry O. Stern [États-Unis] ; Gerhard Nehmiz [Allemagne] ; George Kukolj [Canada] ; Wulf O. Böcher [Allemagne] ; Federico J. Mensa [États-Unis]	Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results
000F61	D. W. Miles [Royaume-Uni] ; S. L. De Haas [Suisse] ; L. Y. Dirix [Belgique] ; G. Romieu [France] ; A. Chan [Australie] ; X. Pivot [France] ; P. Tomczak [Pologne] ; L. Provencher [Canada] ; J. Cortes [Espagne] ; P. R. Delmar [Suisse] ; S. J. Scherer [États-Unis]	Biomarker results from the AVADO phase 3 trial of first-line bevacizumab plus docetaxel for HER2-negative metastatic breast cancer
001242	E. Cardis [Espagne, Canada] ; B K Armstrong [Australie] ; J D Bowman [États-Unis] ; G G Giles [Australie] ; M. Hours [France] ; D. Krewski [Canada] ; M. Mcbride [Canada] ; M E Parent [Canada] ; S. Sadetzki [Israël] ; A. Woodward [Nouvelle-Zélande] ; J. Brown [Australie] ; A. Chetrit [Israël] ; J. Figuerola [Espagne] ; C. Hoffmann [Israël] ; A. Jarus-Hakak [Israël] ; L. Montestruq [France] ; L. Nadon [Canada] ; L. Richardson [Canada] ; R. Villegas [Espagne] ; M. Vrijheid [Espagne]	Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries
001306	Justyna D. Kowalska [Danemark] ; Nina Friis-M Ller [Danemark] ; Ole Kirk [Danemark] ; Wendy Bannister [Royaume-Uni] ; Amanda Mocroft [Royaume-Uni] ; Caroline Sabin [Danemark] ; Peter Reiss [Pays-Bas] ; John Gill [Canada] ; Charlotte Lewden [France] ; Andrew Phillips [Royaume-Uni] ; Antonella D'Arminio Monforte [Italie] ; Matthew Law [Australie] ; Jonathan Sterne [Royaume-Uni] ; Stephane De Wit [Belgique] ; Jens D. Lundgren [Danemark]	The Coding Causes of Death in HIV (CoDe) Project Initial Results and Evaluation of Methodology
001395	Rukshen Weerasooriya [France, Australie] ; Paul Khairy [Canada] ; Jean Litalien [France] ; Laurent Made [Canada] ; Meleze Hocini [France] ; Frederic Sacher [France] ; Nicolas Lellouche [France] ; Sebastien Knecht [France] ; Matthew Wright [France] ; Isabelle Nault [France] ; Shinsuke Miyazaki [France] ; Christophe Scavee [France] ; Jacques Clementy [France] ; Michel Haissaguerre [France] ; Pierre Jais [France]	Catheter Ablation for Atrial Fibrillation: Are Results Maintained at 5 Years of Follow-Up?
001628	N. Swanson [Nouvelle-Zélande] ; G. Montalescot [France] ; K A Eagle [États-Unis] ; S G Goodman [Canada] ; W. Huang [États-Unis] ; D. Brieger [Australie] ; G. Devlin [Nouvelle-Zélande]	Delay to angiography and outcomes following presentation with high-risk, non-ST-elevation acute coronary syndromes: results from the Global Registry of Acute Coronary Events
001640	Harvey D. White [Nouvelle-Zélande] ; Richard Gallo [Canada] ; Marc Cohen [États-Unis] ; Ph. Gabriel Steg [France] ; Philip E. Aylward [Australie] ; Christoph Bode [Allemagne] ; Steve Steinhubl [États-Unis] ; Gilles Montalescot [France]	The use of intravenous enoxaparin in elective percutaneous coronary intervention in patients with renal impairment : Results from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
001691	Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie]	Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
001750	D. M. Reid [Royaume-Uni] ; D. Hosking [Royaume-Uni] ; D. Kendler [Canada] ; M. L. Brandi [Italie] ; J. D. Wark [Australie] ; J. F. Marques-Neto [Brésil] ; G. Weryha [France] ; N. Verbruggen [États-Unis] ; C. M. Hustad [États-Unis] ; E. M. Mahlis [États-Unis] ; M. E. Melton [États-Unis]	A comparison of the effect of alendronate and risedronate on bone mineral density in postmenopausal women with osteoporosis: 24‐month results from FACTS‐International
001A69	Rainer Oberbauer [Autriche] ; Giuseppe Segoloni [Italie] ; Josep M. Campistol [Espagne] ; Henri Kreis [France] ; Alfredo Mota [Portugal] ; Joseph Lawen [Canada] ; Graeme Russ [Australie] ; Josep M. Grinyo [Espagne] ; Giovanni Stallone [Italie] ; Anders Hartmann [Norvège] ; Jose R. Pinto [Portugal] ; Jeremy Chapman [Australie] ; James T. Burke [France] ; Yves Brault [France] ; John F. Neylan [États-Unis]	Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024